Combining pharmacologic, metabolic, and lifestyle interventions may help stabilize systems and preserve resilience
Following the patent expiry of Semaglutide, Mankind Pharma is preparing to launch a generic version of the GLP-1 drug used to treat Type 2 Diabetes and Obesity
Why consistency matters more than intensity Given the months-long timescale of hair cycling, consistent daily application matters far more than occasional intensive treatments
A key study investigating coagulation factors employed a two-sample Mendelian randomization (MR) approach using large-scale genome-wide association study (GWAS) summary statistics from the UK Biobank (4354 cases, 217,500 controls) and FinnGen (8288 cases, 68,969 controls) cohorts to explore causal associations between 11 coagulation factors and endometriosis risk
Patients who are pregnant, nursing, under 18, or have active malignancies shouldn't use this combination